Literature DB >> 20671234

Sphingosine-1-phosphate-dependent activation of p38 MAPK maintains elevated peripheral resistance in heart failure through increased myogenic vasoconstriction.

Judith Hoefer1, M Ali Azam, Jeffrey T E Kroetsch, Howard Leong-Poi, M Abdul Momen, Julia Voigtlaender-Bolz, Elias Q Scherer, Anja Meissner, Steffen-Sebastian Bolz, Mansoor Husain.   

Abstract

RATIONALE: Mechanisms underlying vasomotor abnormalities and increased peripheral resistance exacerbating heart failure (HF) are poorly understood.
OBJECTIVE: To explore the role and molecular basis of myogenic responses in HF. METHODS AND
RESULTS: 10 weeks old C57Bl6 mice underwent experimental myocardial infarction (MI) or sham surgery. At 1 to 12 weeks postoperative, mice underwent hemodynamic studies, mesenteric, cerebral, and cremaster artery perfusion myography and Western blot. Organ weights and hemodynamics confirmed HF and increased peripheral resistance after MI. Myogenic responses, ie, pressure-induced vasoconstriction, were increased as early as 1 week after MI and remained elevated. Vasoconstrictor responses to phenylephrine were decreased 1 week after MI, but not at 2 to 6 weeks after MI, whereas those to endothelin (ET)-1 and sphingosine-1-phosphate (S1P) were increased at all time points after MI. An antagonist (JTE-013) for the most abundant S1P receptor detected in mesenteric arteries (S1P(2)R) abolished the enhanced myogenic responses of HF, with significantly less effect on controls. Mice with genetic absence of sphingosine-kinases or S1P(2)R (Sphk1(-/-); Sphk1(-/-)/Sphk2(+/-); S1P(2)R(-/-)) did not manifest enhanced myogenic responses after MI. Mesenteric arteries from HF mice exhibited increased phosphorylation of myosin light chain, with deactivation of its phosphatase (MLCP). Among known S1P-responsive regulators of MLCP, GTP-Rho levels were unexpectedly reduced in HF, whereas levels of activated p38 MAPK and ERK1/2 (extracellular signal-regulated kinase 1/2) were increased. Inhibiting p38 MAPK abolished the myogenic responses of animals with HF, with little effect on controls.
CONCLUSIONS: Rho-independent p38 MAPK-mediated deactivation of MLCP underlies S1P/S1P(2)R-regulated increases in myogenic vasoconstriction observed in HF. Therapeutic targeting of these findings in HF models deserves study.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20671234     DOI: 10.1161/CIRCRESAHA.110.226464

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  32 in total

Review 1.  The emerging alliance of sphingosine-1-phosphate signalling and immune cells: from basic mechanisms to implications in hypertension.

Authors:  Nicholas Don-Doncow; Yun Zhang; Hana Matuskova; Anja Meissner
Journal:  Br J Pharmacol       Date:  2018-07-03       Impact factor: 8.739

2.  Correlation between genetic polymorphisms within the MAPK1/HIF-1/HO-1 signaling pathway and risk or prognosis of perimenopausal coronary artery disease.

Authors:  Nan Guo; Nan Zhang; Liqiu Yan; Xufen Cao; Jiawang Wang; Yunfei Wang
Journal:  Clin Cardiol       Date:  2017-04-26       Impact factor: 2.882

Review 3.  S1P Signaling and De Novo Biosynthesis in Blood Pressure Homeostasis.

Authors:  Anna Cantalupo; Annarita Di Lorenzo
Journal:  J Pharmacol Exp Ther       Date:  2016-06-17       Impact factor: 4.030

4.  p27 protein protects metabolically stressed cardiomyocytes from apoptosis by promoting autophagy.

Authors:  Xuetao Sun; Abdul Momen; Jun Wu; Hossein Noyan; Renke Li; Rüdiger von Harsdorf; Mansoor Husain
Journal:  J Biol Chem       Date:  2014-05-02       Impact factor: 5.157

5.  Metoprolol impairs resistance artery function in mice.

Authors:  Mostafa H El Beheiry; Scott P Heximer; Julia Voigtlaender-Bolz; C David Mazer; Kim A Connelly; David F Wilson; W Scott Beattie; Albert K Y Tsui; Hangjun Zhang; Kabir Golam; Tina Hu; Elaine Liu; Darcy Lidington; Steffen-Sebastian Bolz; Gregory M T Hare
Journal:  J Appl Physiol (1985)       Date:  2011-07-28

6.  Reduced vascular smooth muscle BK channel current underlies heart failure-induced vasoconstriction in mice.

Authors:  Elaine Wan; Jared S Kushner; Sergey Zakharov; Xiao-Wei Nui; Neelesh Chudasama; Christopher Kelly; Marc Waase; Darshan Doshi; Guoxia Liu; Shinichi Iwata; Takayuki Shiomi; Alexander Katchman; Jeanine D'Armiento; Shunichi Homma; Steven O Marx
Journal:  FASEB J       Date:  2013-01-16       Impact factor: 5.191

Review 7.  Sphingolipid De Novo Biosynthesis: A Rheostat of Cardiovascular Homeostasis.

Authors:  Linda Sasset; Yi Zhang; Teresa M Dunn; Annarita Di Lorenzo
Journal:  Trends Endocrinol Metab       Date:  2016-08-22       Impact factor: 12.015

Review 8.  The TNF-α/sphingosine-1-phosphate signaling axis drives myogenic responsiveness in heart failure.

Authors:  Jeffrey T Kroetsch; Steffen-Sebastian Bolz
Journal:  J Vasc Res       Date:  2013-04-16       Impact factor: 1.934

Review 9.  Sphingosine-1-phosphate receptor 2.

Authors:  Mohamad Adada; Daniel Canals; Yusuf A Hannun; Lina M Obeid
Journal:  FEBS J       Date:  2013-08-19       Impact factor: 5.542

Review 10.  The role of sphingosine-1-phosphate in endothelial barrier function.

Authors:  Brent A Wilkerson; Kelley M Argraves
Journal:  Biochim Biophys Acta       Date:  2014-07-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.